| Asston Pharmaceuticals Limited, formerly Asston Pharmaceuticals Private Limited, held its 2nd Extraordinary General Meeting on July 31, 2026, via video conferencing, where shareholders approved a resolution to issue equity shares on a preferential basis. The company secretary informed shareholders that the electronic voting window will remain open for 15 minutes post the conclusion of the EGM, and the voting results, along with the scrutinizer's report, will be announced within two working days and placed on the company's website and the BSE Limited. |